Riskpilot← Back to searchSign inGet full accessOrganox AB
ABActiveOrg 5566279195Honnörsgatan 12Manufacture of other organic basic chemicals · NACE 2014Est. 20021 employees
Revenue 2025
SEK 43,7M
-7% vs 2024
EBITDA margin
19.0%
+15% vs 2024
Equity ratio
78.6%
Financial strength
Net profit 2025
SEK 5,4M
-7% vs 2024
| Revenue | SEK 43,7M | -7% |
| EBITDA | SEK 8,3M | +15% |
| Net profit | SEK 5,4M | -7% |
| Total assets | SEK 10M | -17% |
| Equity | SEK 7,9M | -5% |
| Employees | 1 | — |
Legal name
Organox AB
Org number
5566279195
Legal form
Aktiebolag
NACE code
2014 · Manufacture of other organic basic chemicals
Founded
21 maj 2002
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets verksamhet skall vara att utveckla, tillverka och sälja organismer och substanser för areella näringar samt därmed förenlig verksamhet.
Address
Honnörsgatan 12
Email
agneta@organox.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 37 608 | 45 444 | 48 781 | 46 950 | 43 652 |
| Staff expenses | — | −1 133 | −1 455 | −1 864 | −1 320 |
| EBITDA | 7 167 | 6 078 | 7 994 | 7 195 | 8 276 |
| Depreciation & amort. | −88 | −104 | −157 | −207 | −177 |
| EBIT | 7 079 | 5 973 | 7 837 | 6 988 | 8 099 |
| Net financials | 38 | 124 | −192 | 185 | −314 |
| Profit before tax | 7 118 | 7 166 | 6 794 | 7 305 | 6 819 |
| Tax | −1 475 | −1 496 | −1 410 | −1 511 | −1 410 |
| Net profit | 5 643 | 5 670 | 5 385 | 5 794 | 5 408 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 18 114 | 16 202 | 10 810 | 12 045 | 10 022 |
| Equity | 7 923 | 7 992 | 7 777 | 8 271 | 7 879 |
| Long-term debt | 82 | 97 | 105 | 86 | 36 |
| Short-term debt | 8 927 | 7 999 | 2 720 | 3 507 | 1 960 |
| Total debt | 9 009 | 8 096 | 2 825 | 3 593 | 1 996 |
EBITDA margin
19.0%
This company
15.8%
Market median
+20% vs market
20212025
Equity ratio
78.6%
This company
38.2%
Market median
+106% vs market
20212025
Return on equity
68.6%
This company
18.4%
Market median
+273% vs market
20212025
Net profit margin
12.4%
This company
8.1%
Market median
+53% vs market
20212025
Asset turnover
4.36×
This company
1.12×
Market median
+289% vs market
20212025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UT Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2023 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arnön utveckling AB
Organox AB Board members of Organox AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Thomas Mikael Cahling | Chief Auditor | 0 companies |
| Eva Agneta Färlin | Board of Directors | 0 companies |
| Jan Erik Stefan Färlin | Board of Directors | 0 companies |
| Emil Per Henrik Gustafsson | Deputy Board Member | 0 companies |
| Sara Lena Färlin Tynelius | Deputy Board Member | 0 companies |